SPRED1 mutations (Legius syndrome): another clinically useful genotype for dissecting the neurofibromatosis type 1 phenotype.

PubWeight™: 1.32‹?› | Rank: Top 10%

🔗 View Article (PMID 19443465)

Published in J Med Genet on May 13, 2009

Authors

G Spurlock1, E Bennett, N Chuzhanova, N Thomas, H-Ping Jim, L Side, S Davies, E Haan, B Kerr, S M Huson, M Upadhyaya

Author Affiliations

1: Institute of Medical Genetics, Cardiff University, Cardiff, UK.

Articles citing this

High Incidence of Noonan Syndrome Features Including Short Stature and Pulmonic Stenosis in Patients carrying NF1 Missense Mutations Affecting p.Arg1809: Genotype-Phenotype Correlation. Hum Mutat (2015) 1.61

Noonan syndrome: clinical aspects and molecular pathogenesis. Mol Syndromol (2010) 1.60

Disorders of dysregulated signal traffic through the RAS-MAPK pathway: phenotypic spectrum and molecular mechanisms. Ann N Y Acad Sci (2010) 1.54

A shared molecular mechanism underlies the human rasopathies Legius syndrome and Neurofibromatosis-1. Genes Dev (2012) 1.33

The pathoetiology of neurofibromatosis 1. Am J Pathol (2011) 1.13

A highly sensitive genetic protocol to detect NF1 mutations. J Mol Diagn (2011) 1.08

Molecular and cellular mechanisms of learning disabilities: a focus on NF1. Annu Rev Neurosci (2010) 1.04

Nonredundant functions for Ras GTPase-activating proteins in tissue homeostasis. Sci Signal (2013) 1.03

SPRED 1 mutations in a neurofibromatosis clinic. J Child Neurol (2010) 1.03

Neurofibromatosis type 1 molecular diagnosis: what can NGS do for you when you have a large gene with loss of function mutations? Eur J Hum Genet (2014) 1.00

Legius syndrome in fourteen families. Hum Mutat (2011) 0.95

Sprouty-related Ena/vasodilator-stimulated phosphoprotein homology 1-domain-containing protein (SPRED1), a tyrosine-protein phosphatase non-receptor type 11 (SHP2) substrate in the Ras/extracellular signal-regulated kinase (ERK) pathway. J Biol Chem (2011) 0.88

What's new in neurofibromatosis? Proceedings from the 2009 NF Conference: new frontiers. Am J Med Genet A (2010) 0.88

The SPRED1 Variants Repository for Legius Syndrome. G3 (Bethesda) (2011) 0.86

SPRED proteins provide a NF-ty link to Ras suppression. Genes Dev (2012) 0.84

Sprouty4 is an endogenous negative modulator of TrkA signaling and neuronal differentiation induced by NGF. PLoS One (2012) 0.83

Identification of SPRED2 (sprouty-related protein with EVH1 domain 2) as a negative regulator of the hypothalamic-pituitary-adrenal axis. J Biol Chem (2011) 0.82

Non-invasive endothelial function assessment in patients with neurofibromatosis type 1: a cross-sectional study. BMC Cardiovasc Disord (2013) 0.78

Can the diagnosis of NF1 be excluded clinically? A lack of pigmentary findings in families with spinal neurofibromatosis demonstrates a limitation of clinical diagnosis. J Med Genet (2013) 0.78

Interaction between a Domain of the Negative Regulator of the Ras-ERK Pathway, SPRED1 Protein, and the GTPase-activating Protein-related Domain of Neurofibromin Is Implicated in Legius Syndrome and Neurofibromatosis Type 1. J Biol Chem (2015) 0.77

Systematic analysis of copy number variants of a large cohort of orofacial cleft patients identifies candidate genes for orofacial clefts. Hum Genet (2015) 0.77

NF1 exon 22 analysis of individuals with the clinical diagnosis of neurofibromatosis type 1. Am J Med Genet A (2010) 0.75

SPRED1 Interferes with K-ras but Not H-ras Membrane Anchorage and Signaling. Mol Cell Biol (2016) 0.75

Neurofibromatosis type 1 (NF1) associated with tumor of the corpus callosum. Childs Nerv Syst (2012) 0.75

Articles by these authors

The Barthel ADL Index: a reliability study. Int Disabil Stud (1988) 9.20

Human gene mutation database-a biomedical information and research resource. Hum Mutat (2000) 6.87

Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial. Lancet (2009) 6.83

Matching using estimated propensity scores: relating theory to practice. Biometrics (1996) 6.73

Live attenuated malaria vaccine designed to protect through hepatic CD8⁺ T cell immunity. Science (2011) 4.72

Severe limb abnormalities after chorion villus sampling at 56-66 days' gestation. Lancet (1991) 4.48

Parental monitoring: association with adolescents' risk behaviors. Pediatrics (2001) 4.15

Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature (1986) 4.13

X-linked anhidrotic (hypohidrotic) ectodermal dysplasia is caused by mutation in a novel transmembrane protein. Nat Genet (1996) 3.90

A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity. J Med Genet (1992) 3.63

Suicide within 12 months of contact with mental health services: national clinical survey. BMJ (1999) 3.61

Using telemedicine for termination of pregnancy with mifepristone and misoprostol in settings where there is no access to safe services. BJOG (2008) 3.40

A clinical study of type 2 neurofibromatosis. Q J Med (1992) 3.23

Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors. Blood (2000) 2.82

An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes. Am J Hum Genet (1993) 2.79

Analysis of limb reduction defects in babies exposed to chorionic villus sampling. Lancet (1994) 2.73

Retracted Enterocolitis in children with developmental disorders. Am J Gastroenterol (2000) 2.70

Smith-Fineman-Myers syndrome in two brothers. Am J Med Genet (1991) 2.70

A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype. Clin Cancer Res (1999) 2.69

Use of free-access minerals. Vet Rec (1992) 2.65

Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration. J Med Genet (2005) 2.56

Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis. Hum Mol Genet (2001) 2.56

Interpreting hospital mortality data. The role of clinical risk adjustment. JAMA (1989) 2.53

Congenital abnormalities in Brazilian children associated with misoprostol misuse in first trimester of pregnancy. Lancet (1998) 2.50

Limb-salvage treatment versus amputation for osteosarcoma of the distal end of the femur. J Bone Joint Surg Am (1986) 2.49

A prospective study of psychological distress and sexual risk behavior among black adolescent females. Pediatrics (2001) 2.48

Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: a European collaborative study. Eur J Hum Genet (1996) 2.40

Treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex. Br Med J (Clin Res Ed) (1986) 2.33

Fetal valproate syndrome and autism: additional evidence of an association. Dev Med Child Neurol (2001) 2.32

D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics (1997) 2.28

An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation. Am J Hum Genet (2006) 2.23

In vitro differentiation of Trypanosoma cruzi under chemically defined conditions. Mol Biochem Parasitol (1985) 2.20

Blind analysis of denaturing high-performance liquid chromatography as a tool for mutation detection. Genomics (1998) 2.19

Predicting hospital-associated mortality for Medicare patients. A method for patients with stroke, pneumonia, acute myocardial infarction, and congestive heart failure. JAMA (1989) 2.19

Failure of regional blockade for caesarean section. Int J Obstet Anesth (2002) 2.17

Exclusion testing for Huntington's disease in pregnancy with a closely linked DNA marker. Lancet (1987) 2.09

Nevoid basal cell carcinoma syndrome: review of 118 affected individuals. Am J Med Genet (1994) 2.06

Long-term mortality after first psychiatric admission. Br J Psychiatry (1997) 2.06

Renal cystic disease in tuberous sclerosis: role of the polycystic kidney disease 1 gene. Am J Hum Genet (1997) 2.06

Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet A (2010) 2.05

Mutation of the gene encoding the ROR2 tyrosine kinase causes autosomal recessive Robinow syndrome. Nat Genet (2000) 2.03

Correlation between fragment size at D4F104S1 and age at onset or at wheelchair use, with a possible generational effect, accounts for much phenotypic variation in 4q35-facioscapulohumeral muscular dystrophy (FSHD) Hum Mol Genet (1995) 2.02

Depression, suicide, and the national service framework. BMJ (2001) 2.02

Absence of linkage of hereditary motor and sensory neuropathy type I to chromosome 1 markers. Genomics (1989) 2.00

Fetal alcohol syndrome: a prospective national surveillance study. Arch Dis Child (2007) 1.98

DNA testing for fragile X syndrome in schools for learning difficulties. Arch Dis Child (1995) 1.98

Arthrogryposis multiplex congenita with maternal autoantibodies specific for a fetal antigen. Lancet (1995) 1.94

Instability versus predictability: the molecular diagnosis of myotonic dystrophy. J Med Genet (1992) 1.94

Diagnostic role of upper gastrointestinal endoscopy in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr (2004) 1.86

Molecular genetics of neurofibromatosis type 1 (NF1). J Med Genet (1996) 1.83

The clinical and diagnostic implications of mosaicism in the neurofibromatoses. Neurology (2001) 1.82

Elastic scattering spectroscopy accurately detects high grade dysplasia and cancer in Barrett's oesophagus. Gut (2006) 1.78

Ethnic differences in satisfaction with mental health services among representative people with psychosis in south London: PRiSM study 4. Br J Psychiatry (1997) 1.78

Women with neurofibromatosis 1 are at a moderately increased risk of developing breast cancer and should be considered for early screening. J Med Genet (2007) 1.77

The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J Clin Psychopharmacol (1990) 1.71

A closer look at water-related geologic activity on Mars. Science (2007) 1.71

Mental disorder and clinical care in people convicted of homicide: national clinical survey. BMJ (1999) 1.71

A clinical and genetic study of the Say/Barber/Biesecker/Young-Simpson type of Ohdo syndrome. Clin Genet (2008) 1.71

Purification and properties of L(+)-lactate dehydrogenase from potato tubers. Biochem J (1972) 1.70

Mineralization of linear alkylbenzene sulfonate by a four-member aerobic bacterial consortium. Appl Environ Microbiol (1991) 1.68

Cost effectiveness of an outpatient multidisciplinary pulmonary rehabilitation programme. Thorax (2001) 1.67

SUMO-1 marks the nuclear inclusions in familial neuronal intranuclear inclusion disease. Exp Neurol (2003) 1.66

Angelman syndrome phenotype associated with mutations in MECP2, a gene encoding a methyl CpG binding protein. J Med Genet (2001) 1.66

What constitutes cerebral palsy? Dev Med Child Neurol (1998) 1.66

Photodamage to human RPE cells by A2-E, a retinoid component of lipofuscin. Invest Ophthalmol Vis Sci (2000) 1.64

Identification and characterization of a two-component sensor-kinase and response-regulator system (DcuS-DcuR) controlling gene expression in response to C4-dicarboxylates in Escherichia coli. J Bacteriol (1999) 1.64

Paternal origin of new mutations in von Recklinghausen neurofibromatosis. Nature (1990) 1.64

A genetic study of type 2 neurofibromatosis in the United Kingdom. II. Guidelines for genetic counselling. J Med Genet (1992) 1.62

Recombination hotspot in NF1 microdeletion patients. Hum Mol Genet (2001) 1.61

Bioterrorism preparedness and response: use of information technologies and decision support systems. Evid Rep Technol Assess (Summ) (2002) 1.61

Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location. Hum Mol Genet (2000) 1.61

Cognitive-behavioral group therapy versus phenelzine in social phobia: long-term outcome. Depress Anxiety (1999) 1.59

Cognitive spatial processing and the regulation of posture. J Exp Psychol Hum Percept Perform (1985) 1.58

Optical observations of comet Hale-Bopp (C/1995 O1) at large heliocentric distances before perihelion. Science (1997) 1.58

Family history taking and genetic counselling in primary care. Fam Pract (1999) 1.58

Reminiscence therapy for dementia. Cochrane Database Syst Rev (2005) 1.57

Booster seats for child passengers: lessons for increasing their use. Inj Prev (2001) 1.55

Koch's or Crohn's--or something else? Int J Clin Pract (1997) 1.54

Tools for monitoring the effectiveness of district maternity referral systems. Health Policy Plan (2001) 1.54

Single night studies in obstructive sleep apnea. Sleep (1991) 1.52

Effects of electrode placement on the efficacy of titrated, low-dose ECT. Am J Psychiatry (1987) 1.51

Genetic alterations in 'normal' luminal and myoepithelial cells of the breast. J Pathol (1999) 1.50

Accuracy of hepatocellular carcinoma detection on multidetector CT in a transplant liver population with explant liver correlation. Clin Radiol (2011) 1.50

Comparison of liver transplantation outcomes from adult split liver and circulatory death donors. Br J Surg (2012) 1.49

MASA syndrome: further clinical delineation and chromosomal localisation. Hum Genet (1989) 1.49

Exuberant expression of chemokine genes by adult human articular chondrocytes in response to IL-1beta. Osteoarthritis Cartilage (2008) 1.49

Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution. Brain (1999) 1.48

Microbial DNA profiling by multiplex terminal restriction fragment length polymorphism for forensic comparison of soil and the influence of sample condition. J Appl Microbiol (2008) 1.45

Intention to undergo prophylactic bilateral mastectomy in women at increased risk of developing hereditary breast cancer. J Clin Oncol (2000) 1.45

"Folate before pregnancy": the impact on women and health professionals of a population-based health promotion campaign in South Australia. Med J Aust (2001) 1.45

Fatal acute fulminant liver failure due to clozapine: a case report and review of clozapine-induced hepatotoxicity. Gastroenterology (1997) 1.44

Multiple coronary artery aneurysms in a child with neurofibromatosis type 1. Eur J Pediatr (2000) 1.44

Longitudinal variation in hepatitis C virus (HCV) viraemia and early course of HCV infection after liver transplantation for HCV cirrhosis: the role of different immunosuppressive regimens. Gut (1999) 1.44

Regional mapping of facioscapulohumeral muscular dystrophy gene on 4q35: combined analysis of an international consortium. Am J Hum Genet (1992) 1.44